Helix
Helix is a company specializing in genetic testing and analysis, offering a variety of services through its CLIA-certified and CAP-accredited laboratory, including hereditary cancer and cardiovascular tests.
Genetic Testing and Analysis Services
Helix offers a wide range of genetic testing and analysis services. This includes tests for hereditary cancer, cardiovascular conditions, and pharmacogenomics. The company leverages its CLIA-certified and CAP-accredited laboratory to ensure high accuracy and reliability in its results. Helix's services are designed to provide personalized healthcare insights based on genetic information, supporting informed decision-making for both individuals and healthcare professionals.
DNA Products and Research Platform
Helix provides a comprehensive platform for accessing a variety of DNA products and research programs. This platform is utilized by health systems, research institutions, and other organizations involved in large-scale genomics initiatives. Through this platform, users can access and analyze genomic data, which helps drive advancements in personalized medicine and genetic research.
Exome+ Sequencing Technology
The company utilizes advanced Exome+ sequencing technology. This enables Helix to sequence exomes comprehensively, capturing more genetic variations compared to traditional methods. This technology supports the company's mission to offer detailed genetic insights and enhance the understanding of genetic influences on health.
Population Genomics Programs
Helix is actively engaged in population genomics programs. These initiatives aim to study the genetic makeup of large populations to identify health trends and risk factors. One notable collaboration is with Sanford Health on a rural population genomics health initiative, focusing on improving healthcare in rural areas through genetic insights. These programs help in creating tailored health strategies and advancing public health monitoring.
Public Health and Viral Surveillance
Helix participates in public health monitoring and viral surveillance efforts. By employing its genomic sequencing capabilities, the company contributes to tracking and understanding viral outbreaks. This work is crucial for informing public health responses and mitigating the spread of infectious diseases. Helix's involvement enhances the global capacity for viral monitoring and public health planning.